In order to investigate the potential context between the centrosomal status, altered separase activity and MDS progression we have investigated the centrosomal phenotype of 26 clinical specimen including 16 MDS patients, 4 patients with sAML and 6 healthy controls. Here, ESPL1 is linked to myelodysplastic syndrome.